Free access to Ginkgo's automated lab infrastructure to speed R&D projects in diagnostics, therapeutics, and vaccines for COVID-19.

Project needs to fit with the infrastructure at Ginkgo. Can see examples of our capabilities here: https://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/

email to: covid-response@ginkgobioworks.com